EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impulse Dyscontrol Symptoms Are Related to Amyloid Beta in Patients With Subjective Cognitive Decline and Mild Cognitive Impairment

Ana Luiza Gonçalves Rochetti, Isadora Cristina Ribeiro, Lucas Luchesi Barnes iD, Liara Rizzi, Italo Karmann Aventurato, Brenda Costa Gonçalves, Marjorie Cristina Rocha da Silva, Marcio Luiz Figueredo Balthazar

Psychogeriatrics · 2026

DOI: 10.1111/psyg.70119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychogeriatrics, 2026. Verfasst von Ana Luiza Gonçalves Rochetti und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, UNICAMP/SP, Campinas, Brazil. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Amyloid beta-Peptides, Alzheimer Disease, Disruptive, Impulse Control, and Conduct Disorders. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The relationship between neuropsychiatric symptoms (NPSs) and Alzheimer's disease (AD) pathophysiology, considering cerebrospinal fluid (CSF) biomarkers, is still not clarified and the available results in the literature are contradictory especially when it comes to the prodromic stages of AD. Clarifying the role of the AD biomarkers in the development of NPS in subjective cognitive decline (SCD) and mild cognitive impairment (MCI) is relevant and can be useful for planning longitudinal interventions in the AD continuum. The present work studies the correlation between NPSs and AD CSF biomarkers in SCD and MCI Brazilian subjects.

Methods

This is a transversal study designed to evaluate the relationship between NPS and CSF AD biomarkers in SCD and MCI individuals. Voluntary participants were recruited through a virtually announced formulary. The inclusion criteria were age 55 years or older, of both sexes, without distinction of ethnicity or socioeconomic status, the presence of cognitive complaints, and that were willing to participate in all research procedures. Exclusion criteria for all subjects included clinical dementia, other neurological or psychiatric diseases, traumatic brain injury that resulted in a loss of consciousness, drug or alcohol addiction, prior chronic exposure to neurotoxic substances, Fazekas scale ≥ 2, and a score on the Montreal Cognitive Assessment (MoCA) less than 17 points. All participants had Pfeffer's Functional Activities Questionnaire < 5 and underwent medical and neuropsychological evaluation.

Results

Seventy‐one patients were included between 2019 and 2022, 54 with MCI and 17 with SCD. A significant correlation ( p : 0.006) was observed between MBI‐C C domain and the concentrations of CSF amyloid‐beta peptide.

Conclusion

The study identified a significant correlation between domain C of the MBI‐C and CSF beta‐amyloid peptide analysing Brazilian patients with SCD and MCI. The results reinforce the hypothesis of the relationship between impulsivity symptoms and amyloid pathology. Further studies involving the correlations between MBI and neuropsychiatric symptoms with AD CSF biomarkers are necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionAmyloid beta-PeptidesAlzheimer DiseaseDisruptive, Impulse Control, and Conduct DisordersHumansMaleFemaleBiomarkersAgedBrazilMiddle AgedNeuropsychological TestsCross-Sectional Studies

Substanzen

BiomarkersAmyloid beta-Peptides

Autor:innen und Institutionen

  • School of Medical Sciences, UNICAMP/SP, Campinas, Brazil.

ORCID-Profile: Lucas Luchesi Barnes

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Rochetti, A. L. G., Ribeiro, I. C., Barnes, L. L., Rizzi, L., Aventurato, I. K., Gonçalves, B. C., da Silva, M. C. R., & Balthazar, M. L. F. (2026). Impulse Dyscontrol Symptoms Are Related to Amyloid Beta in Patients With Subjective Cognitive Decline and Mild Cognitive Impairment. Psychogeriatrics. https://doi.org/10.1111/psyg.70119

Vancouver

Rochetti ALG, Ribeiro IC, Barnes LL, Rizzi L, Aventurato IK, Gonçalves BC, et al. Impulse Dyscontrol Symptoms Are Related to Amyloid Beta in Patients With Subjective Cognitive Decline and Mild Cognitive Impairment. Psychogeriatrics. 2026. doi:10.1111/psyg.70119

BibTeX
@article{Rochetti2026,
  author = {Rochetti, Ana Luiza Gonçalves and Ribeiro, Isadora Cristina and Barnes, Lucas Luchesi and Rizzi, Liara and Aventurato, Italo Karmann and Gonçalves, Brenda Costa and da Silva, Marjorie Cristina Rocha and Balthazar, Marcio Luiz Figueredo},
  title = {Impulse Dyscontrol Symptoms Are Related to Amyloid Beta in Patients With Subjective Cognitive Decline and Mild Cognitive Impairment},
  journal = {Psychogeriatrics},
  year = {2026},
  doi = {10.1111/psyg.70119}
}
Kostenlos starten →